Pentagon Watchdog Clears Microsoft’s Cloud Win Over Amazon

Pentagon Watchdog Clears Microsoft’s Cloud Win Over Amazon

(Bloomberg) -- The Defense Department’s watchdog found no evidence that the Pentagon’s controversial decision to award a $10 billion cloud-computing contract to Microsoft Corp. was the result of interference from President Donald Trump, though it said its probe was limited by the White House.The 317-page report issued Wednesday by the inspector general’s office also found that giving the JEDI contract to a single company -- Microsoft -- rather than dividing it among competitors was “consistent with applicable acquisition standards.”While the Joint Enterprise Defense Infrastructure project was hotly disputed by rival technology companies from the start, the project gained broader attention when Trump publicly expressed concern about the assumption that the contract would go to Amazon.com Inc.After Microsoft was given the award instead, Amazon Web Services, Amazon’s cloud services unit, filed a lawsuit alleging that political interference by Trump cost the company the cloud deal. Amazon said in the suit that the...

3 Frontrunners In COVID-19 Vaccine Development: What You Need To Know

As companies race against time to bring to market a vaccine for the new coronavirus -- SARS-CoV-2 -- that causes COVID-19, three contenders have emerged as frontrunners, having advanced their candidates into the clinics.Moderna Inc (NASDAQ: MRNA), Inovio Pharmaceuticals Inc (NASDAQ: INO) and CanSino Biological Inc./Beijing Institute of Biotechnology are those that have moved out of the crowd, even as the rest are either testing vaccines in labs, in vitro, or in animals in the preclinical stage. Here's brief on the vaccine programs:Moderna Name of the vaccine candidate: mRNA-1273Type: messenger RNA vaccineStatus: enrollment ongoing in Phase 1 studyModerna is working on mRNA-1273 in collaboration with the NIH's National Institute of Allergy and Infectious Diseases. The vaccine encodes a prefusion-stabilized form of the SARS-CoV-2 spike protein. The company said it took just 25 days to go from sequence selection to manufacturing of the vaccine, and 63 days from sequence selection to start...